Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45 results about "URA3" patented technology

URA3 is a gene on chromosome V in Saccharomyces cerevisiae (yeast). Its systematic name is YEL021W. URA3 is often used in yeast research as a "marker gene", that is, a gene to label chromosomes or plasmids. URA3 encodes Orotidine 5'-phosphate decarboxylase (ODCase), which is an enzyme that catalyzes one reaction in the synthesis of pyrimidine ribonucleotides (a component of RNA).

Donor yeast strain for transfer of genetic material

The invention provides a universal yeast donor strain that contains a conditional centromere and a URA3 allele on every chromosome. This strain was constructed in four rounds of crosses of individual conditional chromosome strains using a novel tetrad-based screen to identify segregants in which all marked chromosomes were contained in the same spore. The invention also provides an improved high efficiency method to transfer extrachromosomal genetic material such as plasmid DNA into any Saccharomyces strain for use with the current gene disruption libraries. The method of transfer is mating-based method which uses a kar1 plasmid donor strain that can initiate mating but cannot form a diploid and allows plasmid transfer (plasmoduction) between nuclei in the heterokaryon. kar1 matings have been used to transfer YACs between yeast strains, but previous methods required specialized genetic backgrounds in the recipient strains and suffered from high rates of spurious chromosome transfer (Hugerat, Y., et al. 1994. Genomics 22:108). Plasmoduction with the universal donor strain only requires that the recipient strain be ura3, GAL+ and have another marker available for selection of the transferred plasmid. Counterselection against every donor chromosome also limits the amount of spurious allele transfer. The universal donor strain and the method of the invention are used to screen the yeast gene disruption library with plasmid-based dominant negative alleles of various genes.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Industrial rice wine yeast metabolic engineering bacteria with low-yield urea and building method thereof

The invention discloses industrial rice wine yeast metabolic engineering bacteria with low-yield urea. The building method of the engineering bacteria comprises the following steps: building URA3 gene knockout component, respectively transforming a-type and alpha-type haploid rice wine yeasts, so as to obtain a uracil defect type strain; building a strong promoter containing PGK1p and a high-expression component of a URA3 gene; respectively transforming the a-type and alpha-type haploid rice wine yeasts; integrating into a strain genome by homologous recombination; inserting the PGK1p strong promoter before an initiation codon of a DUR1,2 gene to obtain a prototrophic haploid engineering strain for high expression of the DUR1,2 gene; fusing into diploid again, so as to obtain the industrial rice wine yeast metabolic engineering bacteria with low-yield urea. The engineering bacteria disclosed by the invention are prototrophic, the growth and fermentation abilities are very nearly the same as those of a parent strain, the content of urea and EC in a fermentation liquor can be obviously reduced, and no exogenous gene is led in. Therefore, the industrial rice wine yeast metabolic engineering bacteria are high in biosecurity and have good industrial application prospects.
Owner:JIANGNAN UNIV

Yeast for dietary therapy of diabetes and construction method thereof

The invention describes a yeast for the dietary therapy of diabetes and a construction method thereof. A saccharomyces cerevisiae genome DNA as a template is used for amplifying two sections of rDNA sequences; pYX212 as a template is used for amplifying a nutritional marker gene URA3 and an expression cassette segment driven by a triosephosphate isomerase promoter; the four amplified products are respectively cloned at corresponding loci of pUC18, and thereby an integrating vector pNK1 is obtained. A DNA synthesization point mutation technique is then utilized to remove the restriction sites of dipeptidase VI and trypsin in the natural GLP-1 molecule, so that type I primer segments, type II primer segments and left and right connected filling primer segments are synthesized, and a ten-repeat tandem rolGLP-1 sequence is obtained by the method of step-by-step annealing and one-step connection, and is cloned in the pNK1, so that pNK-GLP is obtained. The pNK-GLP is then linearized, saccharomyces cerevisiae BJ2407 is transformed, and after screening, recombinant yeast SG2 is obtained. Because the rolGLP-1 gene is integrated in yeast chromosome, the recombinant strain can stably and efficiently express the characteristics of the rolGLP-1 and reduce the blood sugar level of a rat with hyperglycaemia, and can be used in the development of yeast biomedicine for treating diabetes.
Owner:NANKAI UNIV

Double-fluorescence screening method for fungal gene knockout

ActiveCN110117609AReduce workloadOmit the verification link of southern blot (blot hybridization)Stable introduction of DNAMicroorganism based processesCompetent cellFungal gene
The invention discloses a double-fluorescence screening method for fungal gene knockout, and relates to the technical field of fungal gene knockout. The method comprises the steps that a 2.9-kb URA3-2micro2_origin fragment in a pYES2 carrier DNA template is amplified, the fragment is inserted into a pCAMBIA1300 carrier, and a pUM carrier is obtained; then, a tef1 promoter, an eGFP gene, a PgpdA promoter, a ble resistance gene, an RFP gene, a TtrpC terminator, an upstream homologous arm of a target gene x and a downstream homologous arm of the target gene x are amplified respectively; finally,a knockout carrier pKO-x of the target gene x is established; the pKO-x is transformed into agrobacterium competent cells, fungi is transformed through an agrobacterium mediated method, antibiotic screening is carried out to obtain a resistance transformant, then fluorescence microscope detection is carried out on the resistance transformant, the resistance transformant is a target transformant ifonly red fluorescence is emitted, the resistance transformant is an ectopic integration transformant if both green fluorescence and red fluorescence exist, and the transformant is a wild type if no fluorescence is emitted. The method can be used for effectively distinguishing the target transformant from the ectopic integration transformant.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Traceless gene editing method for trichoderma fungi

ActiveCN108384797ASolve scientific research problems that are extremely difficult to operateRealize traceless recyclable operationFungiStable introduction of DNAHygromycin BGene Position
The invention relates to a traceless gene editing method for trichoderma fungi. According to the method, the traceless knockout mutant of the trichoderma guizhouense ura3 gene is obtained through twotimes of homologous recombination events and in combination with the resistance screening strategy of hygromycin B and the lethal strategy of 5-FOA; based on the mutant, the knockout fragment containing the ura3 gene expression cassette is inserted at the position of the target gene through the homologous recombination method, and the mutant having the first-time homologous recombination is screened by utilizing the nutrition defect feature of the ura3 traceless mutant; after the second-time homologous recombination, the ura3 gene and the target gene are removed through recombination, at the time, inverse screening is carried out by utilizing the lethal feature of 5-FOA, and thus the traceless mutant with the target gene completely deleted is obtained. The system is optimized sufficiently,the homologous recombination ratio is 15% or above, the single-gene traceless operating period is shortened to be within 15 days, meanwhile, the traceless overexpression of the target gene can be realized, and no exogenous fragments are introduced during the process.
Owner:NANJING AGRICULTURAL UNIVERSITY

Recombinant yeast strain for fermenting erythritol under high nitrogen condition, construction method and application thereof

The invention discloses a recombinant yeast strain for fermenting erythritol under high nitrogen condition, a construction method and an application thereof. The recombinant strain is constructed by:obtaining the SNF1 gene in the whole genome of Yarrowia lipolytica, using the Yarrowia lipolytica genome as a template to separately amplify the upstream and downstream fragments of the SNF1 gene andthe URA3 fragment by PCR reaction, ligating the upstream and downstream fragments of the SNF1 gene to the upstream and downstream of the URA3 fragments by an overlap extension PCR method to obtain aSNF1 gene knockout component, transferring the SNF1 gene knockout module to the selected uracil-deficient Yarrowia lipolytica strain, and screening to obtain the Yarrowia lipolytica recombinant strainin which the SNF1 gene was knocked out. The strain eliminates the coupling between nitrogen hunger stress and erythritol synthesis by knocking out the SNF1 gene of Snf1 protein. The recombinant yeaststrain of the invention can synthesize erythritol under high nitrogen conditions, and the fermentation efficiency is obviously improved, which solves the problem of delayed fermentation and low yieldin industrial production of erythritol.
Owner:HUAIYIN TEACHERS COLLEGE

Method for fermentation production of D-tagatose by saccharomyces cerevisiae

The invention relates to a method for fermentation production of D-tagatose by saccharomyces cerevisiae including the following steps: codons for optimizing gene GalE according to codon preference ofsaccharomyces cerevisiae are built in the saccharomyces cerevisiae expression vector YCplac33 to produce a vector 1, wherein, the expression vector YCplac33 carries ampicillin resistance gene of escherichia coli and a selection marker URA3 gene of saccharomyces cerevisiae; the above recombined carrier 1 is transferred to a wild type saccharomyces cerevisiae W303, wherein, positive monoclonal genesare selected pursuant to the selection marker URA3 of the saccharomyces cerevisiae and the positive monoclonal genes are cultured for extraction of a genome of the yeast to be further verified by PCRto produce a final fermentation strain; the fermentation strain is cultured under a certain condition till bacteria hits a certain concentration; corresponding substrate fructose is added to the strain for a 5-day reaction under 35-36 DEG C and 220-250 rpm to produce D-tagatose, and the D-tagatose is collected, separated and purified. The process has separation and purification procedures only inthe final step of production, and the product purification process is simple.
Owner:嘉兴欣贝莱生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products